减重手术后医疗支出:一项回顾性队列研究
该回顾性队列研究比较了22,698例减重手术患者(RYGB 7,127例,SG 15,571例)与66,769例匹配非手术患者术前3年至术后5.5年的医疗支出。术后长期总支出两组相似(5.5年时差值为-$61,95%CI:-166,52),手术组药物支出较低但住院风险较高。
要点
- 减重手术组长期药物支出较非手术组低(5.5年时低$314,95%CI:-419,-208),但被较高的住院风险抵消。
- 术后5.5年总支出两组相似(差值-$61,95%CI:-166,52)。
- RYGB与SG两种术式术后3.5至5.5年总支出相似。
核心结论
- 减重手术较匹配对照降低药物支出,但未降低长期总支出。
- 两种主要减重术式的支出趋势相似。
研究设计与样本
- 回顾性队列研究,纳入2012年至2019年22,698例减重手术患者(RYGB 7,127例,SG 15,571例)与66,769例匹配非手术患者,使用广义估计方程比较术前3年及术后5.5年的总门诊、住院和药物支出。
主要发现
- 手术组与非手术组匹配良好,女性占80%至81%,平均体重指数44,平均年龄RYGB组47岁、SG组44岁。
- 术前3年两组估算总支出相似(差值$27,95%CI:-42,102)。
- 术后3至5.5年两组总支出降至术前水平以下并趋于相似(5.5年时差值-$61,95%CI:-166,52)。
- 长期门诊支出两组相似。
- 手术组长期药物支出较低(5.5年时低$314,95%CI:-419,-208),但被较高的住院风险抵消。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare expenditures between surgical and matched nonsurgical patients in a retrospective cohort study. BACKGROUND: Bariatric surgery leads to substantial improvements in weight and weight-related conditions, but prior literature on postsurgical health expenditures is equivocal. METHODS: In a retrospective study, total outpatient, inpatient, and medication expenditures 3 years before and 5.5 years after surgery were compared between 22,698 bariatric surgery [n = 7127 Roux-en-Y gastric bypass (RYGB), 15,571 sleeve gastrectomy (SG)] patients from 2012 to 2019 and 66,769 matched nonsurgical patients, using generalized estimating equations. We also compared expenditures between patients receiving the 2 leading surgical procedures in weighted analyses. RESULTS: Surgical and nonsurgical cohorts were well matched, 80% to 81% females, with mean body mass index of 44 and mean age of 47 (RYGB) and 44 (SG) years. Estimated total expenditures were similar between surgical and nonsurgical groups 3 years before surgery ($27 difference, 95% CI: -42, 102), increased 6 months before surgery for surgical patients, and decreased below preperiod levels for both groups after 3 to 5.5 years to become similar (difference at 5.5 years = -$61, 95% CI: -166, 52). Long-term outpatient expenditures were similar between groups. Surgical patients' lower long-term medication expenditures ($314 lower at 5.5 years, 95% CI: -419, -208) were offset by a higher risk of hospitalization. Total expenditures were similar between patients undergoing RYGB and SG 3.5 to 5.5 years after surgery. CONCLUSIONS: Bariatric surgery translated into lower medication expenditures than matched controls, but not lower overall long-term expenditures. Expenditure trends appear similar for the two leading bariatric operations.
引用
- Smith VA, Zepel L, Kawatkar AA, et al. Health Expenditures After Bariatric Surgery: A Retrospective Cohort Study. Ann Surg. 2024. PMID: 38726675. doi:10.1097/SLA.0000000000006333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。